PlainRecalls
FDA Devices Moderate Class II Terminated

MOL3655 Simplexa VZV Swab Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zoster virus (VZV) DNA present in cutaneous and mucocutaneous lesion swabs from patients with signs and symptoms of VZV infection.

Reported: July 22, 2020 Initiated: May 12, 2020 #Z-2549-2020

Product Description

MOL3655 Simplexa VZV Swab Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zoster virus (VZV) DNA present in cutaneous and mucocutaneous lesion swabs from patients with signs and symptoms of VZV infection.

Reason for Recall

Due to a software malfunction in the Multi Assay Suite, there is the probability of increased occurrence of false negative results.

Details

Recalling Firm
DiaSorin Molecular LLC
Units Affected
304 plastic vials (24 vials per box)
Distribution
Worldwide distribution - U.S. Nationwide distribution including in the states of CO, FL, KS, MI, NC, PA, TX, and WA The countries of Austria, Czech Republic, France and Switerland.
Location
Cypress, CA

Frequently Asked Questions

What product was recalled?
MOL3655 Simplexa VZV Swab Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zoster virus (VZV) DNA present in cutaneous and mucocutaneous lesion swabs from patients with signs and symptoms of VZV infection.. Recalled by DiaSorin Molecular LLC. Units affected: 304 plastic vials (24 vials per box).
Why was this product recalled?
Due to a software malfunction in the Multi Assay Suite, there is the probability of increased occurrence of false negative results.
Which agency issued this recall?
This recall was issued by the FDA Devices on July 22, 2020. Severity: Moderate. Recall number: Z-2549-2020.